Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Pulawy – page 14

833 clinical trials in Pulawy, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Pulawy at a glance
833
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

833 trials in Pulawy

Open in trial search

A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Orforglipron hemicalcium
  • Sponsor:Eli Lilly & Co.

Study of ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Kura Oncology Inc.

A study to evaluate the safety and effectiveness of BNT324 and BNT327 in patients with advanced lung cancer

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:BNT324
  • Sponsor:BioNTech SE

A study comparing prasinezumab with placebo for people with early-stage Parkinson's disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Prasinezumab
  • Sponsor:F. Hoffmann-La Roche AG

Testing MK-2870 with pembrolizumab compared to pembrolizumab alone after surgery in patients with non-small cell lung cancer who did not respond fully to treatment

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC

A study comparing odronextamab combined with chemotherapy versus rituximab combined with chemotherapy in adults with previously untreated follicular lymphoma

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Regeneron Pharmaceuticals Inc.

A Study of Telisotuzumab Adizutecan Compared to Standard Treatment in Adults with Advanced Non-Small Cell Lung Cancer After Previous Treatment

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Amivantamab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

A study to test if empasiprubart can improve function and is safe for adults with chronic inflammatory demyelinating polyneuropathy

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Empasiprubart
  • Sponsor:Argenx

Study of Revumenib and Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia with NPM1 Gene Mutation

Registered drug
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Syndax Pharmaceuticals Inc.

A study of RO7268489 added to ocrelizumab compared to placebo in adults with progressive multiple sclerosis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:F. Hoffmann-La Roche AG

Testing Treprostinil Palmitil Inhalation Powder for Improving Exercise Ability in Patients with Pulmonary Hypertension Related to Interstitial Lung Disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Treprostinil Palmitil
  • Sponsor:Insmed Inc.

A Study of Amivantamab With Carboplatin and Pembrolizumab for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Amivantamab
  • Sponsor:Janssen Cilag International

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Pulawy

What the registry says about research in the country

01 Respiratory Health Research

Innovative clinical trials focusing on respiratory viral infections in older adults, including studies of novel vaccines against RSV and human metapneumovirus. Additional research examines influenza prevention strategies using adjuvanted vaccines.

  • RSV and hMPV Prevention
  • Influenza Protection
  • Vaccine Co-administration Studies

These trials aim to enhance protection for adults aged 60 and older against common respiratory infections.

02 Metabolic Disorders

Comprehensive research into obesity and type 2 diabetes management, evaluating new therapeutic approaches for weight management and glycemic control. Studies include both standalone obesity treatments and combined approaches for diabetes management.

  • Weight Management Therapies
  • Diabetes Control
  • Combined Treatment Approaches

Trials focus on developing effective treatments for metabolic conditions affecting quality of life.

03 Cardiovascular Research

Advanced studies in cardiovascular health, investigating treatments for acute myocardial infarction, atrial fibrillation, and chronic heart failure. Research includes novel approaches to prevent strokes and manage various heart conditions.

  • Heart Attack Treatment
  • Stroke Prevention
  • Heart Failure Management

These trials aim to improve outcomes for patients with various cardiac conditions.

04 Dermatological Studies

Research focusing on psoriasis treatment, evaluating new oral medications for mild-to-moderate cases. Studies aim to determine optimal dosing and efficacy of novel therapeutic approaches.

  • Psoriasis Treatment
  • Oral Medication Studies
  • Dose Optimization

Trials are designed to advance treatment options for common skin conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.